Freedom Investment Management, Inc. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 177 filers reported holding NEKTAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
Freedom Investment Management, Inc. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2018$261,000
-72.6%
7,935
-43.0%
0.02%
-66.7%
Q3 2018$954,000
+347.9%
13,927
+219.4%
0.06%
+361.5%
Q2 2018$213,000
-77.8%
4,360
-51.8%
0.01%
-73.5%
Q1 2018$960,000
+278.0%
9,039
+112.5%
0.05%
+276.9%
Q4 2017$254,000
+10.4%
4,254
-68.9%
0.01%
-23.5%
Q4 2015$230,00013,6620.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2016
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders